We work Hard to get you posted with latest updates

http://We%20work%20Hard%20to%20get%20you%20posted%20with%20latest%20updates

Spend time learning about the different aspects of that topic from experts in the field.

Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy

Unwrap our new Directory

http://Unwrap%20our%20new%20Directory

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

Zentiva

Advertisement

cGxPJobs Banner

Private Equity Firm GTCR to Acquire Zentiva from Advent, Expanding Pharma Reach

Prague, Czech Republic; London, UK; Chicago, US – September 11, 2025 – Zentiva, a leading European generics pharmaceutical company,...

By cGxPwire Editor
September 11, 2025

Read More

Advertisement

cGxPJobs

Recent Posts

01

Bio-Pharma

Synthetic Design Lab Unveils Logic-Gated ADC Platform
April 20, 2026
02

.Clinical

Monopar Reports Phase 3 ALXN1840 Data at AAN 2026
April 20, 2026
03

.Clinical

EpiBiologics Doses First Patient in EPI-326 Phase 1 Study
April 20, 2026
04

Bio-Pharma Pharma

Nanobiotix Reports Nanoprimer Breakthrough at AACR 2026
April 20, 2026
05

MedTech

Philips Verida AI Spectral CT Wins FDA 510(k) Clearance
April 20, 2026

Advertisement

Copyright © 2026 cGxP.wire | Made by 3styler

Directory

Home
Pharma
Bio-Pharma
MedTech
Veterinary
Cosmetics
Food
.Clinical
.Tech
.edu
.gov
M&A
.VC

Start typing and press Enter to search

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website